Hui Xiong

机构：Ganzhou People's Hospital, Shanghai CASB Biotechnology (China), Wuchang University of Technology, Wuhan University of Science and Technology · ORCID：0000-0002-2082-4598

发表论文 32 篇 · 总被引 1432 次 · h-index 10

代表论文

• Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial (2023 · Cancer Cell · 被引 122)
• Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial (2019 · The Lancet Haematology · 被引 50)
• Efficacy and safety of acupuncture in treating acute low back pain: a systematic review and bayesian network meta-analysis (2021 · Annals of Palliative Medicine · 被引 22)
• Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment (2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 18)
• Evaluation of the efficacy and safety of elemene in treating malignant pleural effusion caused by tumors (2018 · Medicine · 被引 15)
• Folate Status and Mortality in US Adults With Diabetes: A Nationally Representative Cohort Study (2022 · Frontiers in Cardiovascular Medicine · 被引 11)